74 related articles for article (PubMed ID: 23973176)
1. Prostate cancer incidence in light of the spatial distribution of another screening-detectable cancer.
Gregorio DI; Samociuk H
Spat Spatiotemporal Epidemiol; 2013 Sep; 6():1-6. PubMed ID: 23973176
[TBL] [Abstract][Full Text] [Related]
2. Geographic distribution of prostate cancer incidence in the era of PSA testing, Connecticut, 1984 to 1998.
Gregorio DI; Kulldorff M; Sheehan TJ; Samociuk H
Urology; 2004 Jan; 63(1):78-82. PubMed ID: 14751353
[TBL] [Abstract][Full Text] [Related]
3. The fall in incidence of prostate carcinoma. On the down side of a prostate specific antigen induced peak in incidence--data from the Utah Cancer Registry.
Stephenson RA; Smart CR; Mineau GP; James BC; Janerich DT; Dibble RL
Cancer; 1996 Apr; 77(7):1342-8. PubMed ID: 8608513
[TBL] [Abstract][Full Text] [Related]
4. Assessing contamination and compliance in the prostate component of the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial.
Pinsky PF; Blacka A; Kramer BS; Miller A; Prorok PC; Berg C
Clin Trials; 2010 Aug; 7(4):303-11. PubMed ID: 20571134
[TBL] [Abstract][Full Text] [Related]
5. Recent trends in prostate cancer testing and incidence among men under age of 50.
Li J; German R; King J; Joseph D; Thompson T; Wu XC; Ajani U; Tai E
Cancer Epidemiol; 2012 Apr; 36(2):122-7. PubMed ID: 22112545
[TBL] [Abstract][Full Text] [Related]
6. Estimating the magnitude of colorectal cancers prevented during the era of screening: 1976 to 2009.
Yang DX; Gross CP; Soulos PR; Yu JB
Cancer; 2014 Sep; 120(18):2893-901. PubMed ID: 24894740
[TBL] [Abstract][Full Text] [Related]
7. Annual report to the nation on the status of cancer, 1975-2002, featuring population-based trends in cancer treatment.
Edwards BK; Brown ML; Wingo PA; Howe HL; Ward E; Ries LA; Schrag D; Jamison PM; Jemal A; Wu XC; Friedman C; Harlan L; Warren J; Anderson RN; Pickle LW
J Natl Cancer Inst; 2005 Oct; 97(19):1407-27. PubMed ID: 16204691
[TBL] [Abstract][Full Text] [Related]
8. Place of residence effect on likelihood of surviving prostate cancer.
Gregorio DI; Huang L; DeChello LM; Samociuk H; Kulldorff M
Ann Epidemiol; 2007 Jul; 17(7):520-4. PubMed ID: 17448679
[TBL] [Abstract][Full Text] [Related]
9. Prostate-specific antigen screening for prostate cancer and the risk of overt metastatic disease at presentation: analysis of trends over time.
Scosyrev E; Wu G; Mohile S; Messing EM
Cancer; 2012 Dec; 118(23):5768-76. PubMed ID: 22847578
[TBL] [Abstract][Full Text] [Related]
10. Bias due to missing SEER data in D'Amico risk stratification of prostate cancer.
Elliott SP; Johnson DP; Jarosek SL; Konety BR; Adejoro OO; Virnig BA
J Urol; 2012 Jun; 187(6):2026-31. PubMed ID: 22498210
[TBL] [Abstract][Full Text] [Related]
11. PSA screening and deaths from prostate cancer after diagnosis--a population based analysis.
Wachtel MS; Nelius T; Haynes AL; Dahlbeck S; de Riese W
Prostate; 2013 Sep; 73(12):1365-9. PubMed ID: 23649537
[TBL] [Abstract][Full Text] [Related]
12. Use of low free to total PSA ratio in prostate cancer screening: detection rates, clinical and pathological findings in Brazilian men with serum PSA levels <4.0 ng/mL.
Faria EF; Carvalhal GF; dos Reis RB; Tobias-Machado M; Vieira RA; Reis LO; Nogueira L; Machado RD; Freitas CH; Magnabosco WJ; Mauad EC; Carvalho AL
BJU Int; 2012 Dec; 110(11 Pt B):E653-7. PubMed ID: 22892057
[TBL] [Abstract][Full Text] [Related]
13. Exploring implications of Medicaid participation and wait times for colorectal screening on early detection efforts in Connecticut--a secret-shopper survey.
Patel VB; Nahar R; Murray B; Salner AL
Conn Med; 2013 Apr; 77(4):197-203. PubMed ID: 23691732
[TBL] [Abstract][Full Text] [Related]
14. Spatial analysis of prostate cancer incidence and race in Virginia, 1990-1999.
Oliver MN; Smith E; Siadaty M; Hauck FR; Pickle LW
Am J Prev Med; 2006 Feb; 30(2 Suppl):S67-76. PubMed ID: 16458792
[TBL] [Abstract][Full Text] [Related]
15. Geographic patterns of prostate cancer mortality and variations in access to medical care in the United States.
Jemal A; Ward E; Wu X; Martin HJ; McLaughlin CC; Thun MJ
Cancer Epidemiol Biomarkers Prev; 2005 Mar; 14(3):590-5. PubMed ID: 15767335
[TBL] [Abstract][Full Text] [Related]
16. Colorectal cancer incidence in the United States, 1999-2004 : an updated analysis of data from the National Program of Cancer Registries and the Surveillance, Epidemiology, and End Results Program.
Rim SH; Seeff L; Ahmed F; King JB; Coughlin SS
Cancer; 2009 May; 115(9):1967-76. PubMed ID: 19235249
[TBL] [Abstract][Full Text] [Related]
17. The clinical burden of prostate cancer in Canada: forecasts from the Montreal Prostate Cancer Model.
Grover SA; Coupal L; Zowall H; Rajan R; Trachtenberg J; Elhilali M; Chetner M; Goldenberg L
CMAJ; 2000 Apr; 162(7):977-83. PubMed ID: 10763395
[TBL] [Abstract][Full Text] [Related]
18. Association of colorectal cancer and prostate cancer and impact of radiation therapy.
Huo D; Hetzel JT; Roy H; Rubin DT
Cancer Epidemiol Biomarkers Prev; 2009 Jul; 18(7):1979-85. PubMed ID: 19531678
[TBL] [Abstract][Full Text] [Related]
19. Race-specific geography of prostate cancer incidence.
DeChello LM; Gregorio DI; Samociuk H
Int J Health Geogr; 2006 Dec; 5():59. PubMed ID: 17176460
[TBL] [Abstract][Full Text] [Related]
20. Epidemiology of the four major cancers in South Dakota.
Clarke J
S D Med; 2010; Spec No():6-14. PubMed ID: 20397486
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]